Progestins in Hormone Replacement Therapies Reactivate Cancer Stem Cells in Women with Preexisting Breast Cancers: A Hypothesis

Por Horwitz, Kathryn B., Sartorius, Carol A.
Publicado em 2008

Progesterone regulation of stem and progenitor cells in normal and malignant breast

Por Axlund, Sunshine Daddario, Sartorius, Carol A.
Publicado em 2011

Steroid Hormones, Steroid Receptors, and Breast Cancer Stem Cells

Por Finlay-Schultz, Jessica, Sartorius, Carol A.
Publicado no J Mammary Gland Biol Neoplasia (2015)

Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts

Por Matthews, Shawna B., Sartorius, Carol A.
Publicado no Horm Cancer (2016)

Ovarian steroid hormones: what's hot in the stem cell pool?

Por Cittelly, Diana M, Richer, Jennifer K, Sartorius, Carol A
Publicado em 2010

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies

Por Hanna, Colton, Kwok, Letty, Finlay-Schultz, Jessica, Sartorius, Carol A., Cittelly, Diana M.
Publicado no J Vis Exp (2016)

Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts

Por Horwitz, Kathryn B., Dye, Wendy W., Harrell, Joshua Chuck, Kabos, Peter, Sartorius, Carol A.
Publicado em 2008

Myosin Heavy Chains IIa and IId Are Functionally Distinct in the Mouse

Por Sartorius, Carol A., Lu, Brian D., Acakpo-Satchivi, Leslie, Jacobsen, Renee P., Byrnes, William C., Leinwand, Leslie A.
Publicado em 1998

Progesterone-Inducible Cytokeratin 5-Positive Cells in Luminal Breast Cancer Exhibit Progenitor Properties

Por Axlund, Sunshine Daddario, Yoo, Byong Hoon, Rosen, Rachel B., Schaack, Jerome, Kabos, Peter, LaBarbera, Daniel V., Sartorius, Carol A.
Publicado em 2012

Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers

Por Kabos, Peter, Haughian, James M., Wang, Xinshuo, Dye, Wendy W., Finlayson, Christina, Elias, Anthony, Horwitz, Kathryn B., Sartorius, Carol A.
Publicado em 2010

A High-Content Assay to Identify Small-Molecule Modulators of a Cancer Stem Cell Population in Luminal Breast Cancer

Por Yoo, Byong Hoon, Axlund, Sunshine Daddario, Kabos, Peter, Reid, Brian G., Schaack, Jerome, Sartorius, Carol A., LaBarbera, Daniel V.
Publicado em 2012

Live Multicellular Tumor Spheroid Models For High-Content Imaging and Screening In Cancer Drug Discovery

Por Reid, Brian G., Jerjian, Taleen, Patel, Purvi, Zhou, Qiong, Yoo, Byong Hoon, Kabos, Peter, Sartorius, Carol A., LaBarbera, Daniel V.
Publicado em 2014

Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a

Por Finlay-Schultz, Jessica, Cittelly, Diana M., Hendricks, Peter, Patel, Purvi, Kabos, Peter, Jacobsen, Britta M., Richer, Jennifer K., Sartorius, Carol A.
Publicado no Oncogene (2014)

Cytokeratin 5 positive cells represent a therapy resistant subpopulation in epithelial ovarian cancer

Por Corr, Bradley R., Finlay-Schultz, Jessica, Rosen, Rachel B., Qamar, Lubna, Post, Miriam D., Behbakht, Kian, Spillman, Monique A., Sartorius, Carol A.
Publicado no Int J Gynecol Cancer (2015)

Tissue Specific Pathways for Estrogen Regulation of Ovarian Cancer Growth and Metastasis

Por Spillman, Monique A., Manning, Nicole G., Dye, Wendy W., Sartorius, Carol A., Post, Miriam D., Harrell, J. Chuck, Jacobsen, Britta M., Horwitz, Kathryn B.
Publicado em 2010

Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and tra...

Por Iwanaga, Ritsuko, Wang, Chu-An, Micalizzi, Douglas S, Harrell, J Chuck, Jedlicka, Paul, Sartorius, Carol A, Kabos, Peter, Farabaugh, Susan M, Bradford, Andrew P, Ford, Heide L
Publicado em 2012

Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4

Por Cittelly, Diana M., Finlay-Schultz, Jessica, Howe, Erin N., Spoelstra, Nicole S., Axlund, Sunshine Daddario, Hendricks, Peter, Jacobsen, Britta M., Sartorius, Carol A., Richer, Jennifer K.
Publicado no Oncogene (2012)

The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis

Por Wellberg, Elizabeth A., Johnson, Stevi, Finlay-Schultz, Jessica, Lewis, Andrew S., Terrell, Kristina L., Sartorius, Carol A., Abel, E. Dale, Muller, William J., Anderson, Steven M.
Publicado no Breast Cancer Res (2016)

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

Por Kabos, Peter, Finlay-Schultz, Jessica, Li, Chunling, Kline, Enos, Finlayson, Christina, Wisell, Joshua, Manuel, Christopher A., Edgerton, Susan M., Harrell, J. Chuck, Elias, Anthony, Sartorius, Carol A.
Publicado em 2012

Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism

Por Sartorius, Carol A., Hanna, Colton T., Gril, Brunilde, Cruz, Hazel, Serkova, Natalie J., Huber, Kendra M., Kabos, Peter, Schedin, Troy B., Borges, Virginia F., Steeg, Patricia S., Cittelly, Diana M.
Publicado no Oncogene (2015)